A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2002
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254111A1 Novel vitamin d analogues
11/06/2002	EP1253966A2 Substances and agents for positively influencing collagen
11/06/2002	EP1253928A2 Novel haptotactic peptides
11/06/2002	EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002	EP1253920A1 An essential constituent and method of use for maintaining hair coloration or reversing hair discoloration
11/06/2002	EP1253906A1 Cosmetic preparations containing waltheria indica extracts
11/06/2002	EP1253904A2 Extracts from residues left in the production of wine
11/06/2002	EP1112076A4 Polymeric compounds and methods of formulating same
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1007065A4 Preparation of collagen
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002	CN1378554A Novel fusidic acid derivatives
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378546A Antibiotic sultam and sultone drived oxazolidiones
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378463A Sterilized cyanoacrylate solutions containing thickeners
11/06/2002	CN1378460A Skin immune function controlling agents
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002	CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels
11/06/2002	CN1378441A Use of conjugated linoleic acid (CLA) for topical treatment of cellulite
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002	CN1377699A Nano aloe and its preparing method and use
11/06/2002	CN1377687A Medicine for burn and scald
11/06/2002	CN1377686A Traditional Chinese medicine composition for curing acne
11/06/2002	CN1377685A Chinese medicine composition for curing chloasma
11/06/2002	CN1377681A Wart clearing liquid
11/06/2002	CN1377659A Rash-eliminating and psoriasis-treating medicine liquid
11/06/2002	CN1377653A Medical paste for burn
11/06/2002	CN1377651A Medicine kuchuangsan for curing bed sore
11/06/2002	CN1377648A Imiquimod or its derivative liposome for local skin and its preparing method and use
11/06/2002	CN1377643A Health article containing tea polyphenol for resisting poor uranium bomb and preventing leukemia
11/06/2002	CN1377640A External preparatino for skin
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/06/2002	CN1093767C Protein kinase C inhibitors
11/06/2002	CN1093757C Skin care composition containing amide and retinol or rectinyl ester
11/06/2002	CN1093755C Topical composition for inhibiting hair growth
11/05/2002	US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476002 Treatment of chronic inflammatory diseases with CM101/GBS toxin
11/05/2002	US6475609 Glitter
11/05/2002	US6475499 Composition for washing keratin materials, based on weakly ethoxylated sorbitan ester
11/05/2002	US6475490 Compositions and methods for promoting tissue repair using heat shock proteins
11/05/2002	CA2205366C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
11/05/2002	CA2011833C Novel polypeptide and production thereof
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085905A1 Novel adenine derivatives
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085890A1 Benzimidazolone derivatives
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085868A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
10/31/2002	WO2002085864A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085422A1 Drug delivery matrices to enhance wound healing
10/31/2002	WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002	WO2002085402A1 Methods and compositions for treating oral and eosophageal lesions
10/31/2002	WO2002085392A1 Method for using puerariae radix, puerariae radix flavone extract and preparation containing puerarin in the prevention and treatment of new indications
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085362A2 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base
10/31/2002	WO2002085349A1 Use of active substance combinations from alpha lipoic acid and substances that absorb light in the uv-a and/or uv-b range for use in the treatment and/or prophylaxis of undesired cutaneous pigmentation
10/31/2002	WO2002085328A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085123A1 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
10/31/2002	WO2002076935A8 Novel a-lipoic acid derivative and use thereof
10/31/2002	WO2002068381A3 Aryl-n-cyanoguanidines and methods related thereto
10/31/2002	WO2002067879A3 Material composition and oral galenic form against hair loss and brittle nails
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002064574A3 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	WO2002051855A3 Motilide compounds
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	WO2001058855A9 Use of androgen receptor suppressors
10/31/2002	WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
10/31/2002	WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis

1 ... 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 ... 1065